Hengjian Li
Papers
1
Total Citations
1
H-Index
1
About
Hengjian Li is a researcher whose work centers on the surgical management of inflammatory bowel disease (IBD), with a particular focus on evaluating the economic and clinical outcomes of surgical interventions. His most notable contribution is the scoping review "Cost-Effectiveness and Cost Only Studies for Inflammatory Bowel Disease Surgery," published in 2025, which systematically synthesizes the existing evidence on the financial implications of IBD surgeries. This work is critical for healthcare decision-makers, as it highlights gaps in cost-effectiveness research and provides a foundation for more economically sustainable surgical practices. While his citation count is still emerging, Li’s research addresses a vital intersection of surgery, health economics, and patient care, offering insights that can guide resource allocation in gastroenterology. His dedication to evidence-based surgery and cost analysis positions him as a thoughtful contributor to the field, with potential for significant impact as his findings inform future clinical guidelines and policy.
Research Focus
Key Achievements
Top Papers
- 1